Skip to main content
. 2017 Jul 26;8(52):90430–90443. doi: 10.18632/oncotarget.19563

Figure 4. Kaplan-Meier progression-free survival (PFS) curves of patients in Group 1 vs. Group 3 (no exon 20 insertion [20-INS]).

Figure 4

Patients in Group 1 are represented by the solid (green) line and patients in Group 3 are represented by the dashed (red) line.